
Thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy, Graves’ ophthalmopathy, or Graves’ orbitopathy, is a debilitating and painful autoimmune disease that causes eye bulging and vision change. In serious cases, TED can lead to loss of vision and blindness. The primary pathophysiology of TED is thought to occur via activating autoantibodies to thyrotropin receptors (TSHRs) on orbital fibroblasts.
Building an innovative biopharma company that invests in, develops and commercializes life-changing drug therapies.
4149 Liberty Canyon Rd
Agoura Hills, CA 91301
651 Gateway Blvd, 6th Floor
South San Francisco, CA 94080
©2025 ACELYRIN, INC. All Rights Reserved. | ACELYRIN and the ACELYRIN logo are trademarks of ACELYRIN, INC.

More Stories
PP-26: What’s at Stake for the Internet and Where We Stand
There Are 6.3 Billion People Connected to the Internet, Yet 2 Billion Remain Offline
Digital Networks Act: The European Parliament Must Correct Course